Medical Equipment Companies By Pb Ratio

Price To Book
Price To BookEfficiencyMarket RiskExp Return
1AVR Anteris Technologies Global
91.17
 0.00 
 4.55 
(0.02)
2NPCE Neuropace
48.92
 0.06 
 3.88 
 0.24 
3BSGM BioSig Technologies, Common
36.58
(0.16)
 8.31 
(1.30)
4MDAI Spectral AI
29.88
(0.05)
 6.57 
(0.33)
5ESTA Establishment Labs Holdings
21.55
 0.01 
 5.81 
 0.06 
6DXCM DexCom Inc
13.72
(0.03)
 2.38 
(0.08)
7MLSS Milestone Scientific
10.89
 0.08 
 5.25 
 0.42 
8NMTC Neuroone Medical Technologies
10.78
 0.10 
 5.33 
 0.52 
9NRXS Neuraxis,
8.03
(0.02)
 4.21 
(0.09)
10MGRM Monogram Orthopaedics Common
7.79
 0.05 
 8.30 
 0.42 
11ECOR Electrocore LLC
7.62
(0.22)
 5.10 
(1.13)
12WRBY Warby Parker
6.72
(0.10)
 3.50 
(0.35)
13OM Outset Medical
6.63
(0.06)
 7.88 
(0.50)
14NTRB Nutriband
6.49
 0.14 
 9.58 
 1.33 
15FEMY Femasys
6.14
 0.15 
 4.37 
 0.65 
16MDXG MiMedx Group
6.06
(0.10)
 1.79 
(0.18)
17NAYA NAYA Biosciences,
5.97
(0.20)
 8.92 
(1.75)
18BDMD Baird Medical Investment
5.97
 0.12 
 81.25 
 9.94 
19NVCR Novocure
5.9
(0.24)
 2.89 
(0.69)
20ELMD Electromed
4.85
(0.08)
 3.38 
(0.26)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities. Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.